Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. United States/
    2. STELARA® (ustekinumab) Approved by the U.S. Food and Drug Administration to Treat Pediatric Patients with Active Psoriatic Arthritis

    STELARA® (ustekinumab) Approved by the U.S. Food and Drug Administration to Treat Pediatric Patients with Active Psoriatic Arthritis

    August 1, 2022
    August 1, 2022

    Download the PDF